Anwesha Banerjee, Ph.D.
Neuroscientist · Senior Medical Science Liaison · TEDx Speaker · 2nd VP, Toastmasters International

AnweshaBanerjee, Ph.D.

Bridging the gap between scientific discovery and patient care. Championing mental health, one conversation at a time.

Scientist at heart.
Storyteller by choice.

◉ Roots in Kolkata, India · Now in San Jose, California

I'm a neuroscientist and Medical Science Liaison who believes science only matters when it reaches people. My work at Axsome Therapeutics sits at the intersection of cutting-edge sleep research and real patient outcomes — translating complex science into conversations that move healthcare forward.

Beyond the lab and the clinic, I've spent years cultivating the craft of communication. As a TEDx Speaker and Second Vice President of Toastmasters International, I've coached and inspired thousands on turning stage fright into a superpower, using the very neuroscience I study.

Rooted in a deep curiosity for how the brain works, I carry a strong conviction that better science communication is one of the most urgent needs of our time — and mental health advocacy, one of its most important applications.

🧠Neuroscience
🎤Public Speaking
🤝KOL Development
📊Strategic Thinking
💬Strategic Comms
🌿Mental Health Advocacy
🔬Drug Development
🌐Cross-functional Leadership
Anwesha Banerjee, Ph.D.
Find me online
A neuroscientist who discovered that the cure for stage fright isn't avoiding the stage — it's understanding what your brain is doing when you're standing on it.
Senior Medical Science Liaison · Axsome Therapeutics
Jul 2026 – Present · San Francisco Bay Area (Remote)
Serving as a senior scientific expert and trusted resource for healthcare professionals in sleep therapeutics. Partnering with leading physicians to translate the latest scientific evidence into clinical practice, shaping research priorities and medical strategy to improve outcomes for patients with sleep disorders.
Jul 2026 – Present
Axsome Therapeutics
Senior Medical Science Liaison
Senior scientific expert and field liaison in sleep therapeutics — partnering with leading physicians to translate emerging research into clinical practice and shaping medical strategy across the San Francisco Bay Area.
Aug 2026 – Present
Toastmasters International
Second Vice President · Board of Directors
Elected at the 2026 International Convention in Vancouver, Canada. Works with the Board to shape the policies and strategic direction of the world's leading communication and leadership organization — serving 265,000+ members across nearly 150 countries.
Jun 2024 – Jul 2026 · 2 yrs 2 mos
Axsome Therapeutics
Medical Science Liaison
Scientific expert and field liaison in sleep therapeutics — collaborating with clinicians, gathering field insights, and supporting research and development in the mental health space. Based in San Jose, California.
Aug 2022 – Aug 2024 · 2 yrs
Toastmasters International
Member, Board of Directors
Elected to the Board of Directors of the world's leading organization devoted to communication and leadership. Participated in strategic plan development, high-level policy direction, and financial oversight of the organization.
Feb 2022 – May 2024 · 2 yrs 3 mos
Annexon Biosciences
Scientist II
Led preclinical programs to develop therapeutic strategies for neurological and autoimmune disorders. Expert in in vivo model development, target validation, biomarker screening, and cross-functional CRO collaborations.
Jun 2015 – Mar 2022 · 6 yrs 10 mos
Emory University School of Medicine
Assistant Scientist (Apr 2019 – Mar 2022) · Postdoctoral Research Fellow (Jun 2015 – Mar 2019)
Researched molecular and behavioral deficits in animal models of Fragile X syndrome and Myotonic Dystrophy. Mentored research associates and contributed to CNS research strategy.
Jul 2016 – Jun 2021 · 5 yrs
Toastmasters International
District Director (2020–2021) · Program Quality Director (2019–2020) · Club Growth Director (2016–2019)
Progressive leadership across district-level roles — driving club growth, member retention, program quality, and district-wide strategic initiatives across Greater Atlanta Area.
Ph.D., Neuroscience
The University of Texas at Dallas
2011 – 2015
M.S., Cognition & Neuroscience
The University of Texas at Dallas
2009 – 2011
Executive Education — Data Science
UC Berkeley
2019
M.S., Biotechnology
Bangalore University
India
Licenses & Certifications
MSL Industry Certified — Cheeky Scientist (2021) Drug Development — Coursera / UCSD (2019) Business Foundations Specialization — Wharton / Coursera (2016)
Neuroscience Medical Affairs Drug Development Sleep Therapeutics KOL Development Molecular Biology In Vivo Model Development Target Validation Clinical Research Strategic Communications Public Speaking Cross-functional Leadership Strategic Planning Organizational Leadership Mental Health Advocacy
Peer-Reviewed Publications
Research spanning autism, Fragile X syndrome, ALS/FTD, narcolepsy, and neurodevelopmental disorders — from molecular mechanisms to therapeutic strategies.
Narcolepsy Autism Fragile X Syndrome Neurodevelopmental Disorders Repeat Expansion Disorders ALS / FTD
View on Google Scholar ↗
500+
Total Citations
10+
Publications
150
Top Cited Paper
Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism
A Banerjee, F García-Oscos, S Roychowdhury, LC Galindo, S Hall, et al.
International Journal of Neuropsychopharmacology, 16(6), 1309–1318
150
cited by
2013
Aberrant RNA translation in fragile X syndrome: From FMRP mechanisms to emerging therapeutic strategies
A Banerjee, MF Ifrim, AN Valdez, N Raj, GJ Bassell
Brain Research, 1693, 24–36
139
cited by
2018
Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36
Neuron
Neuron
82
cited by
2020
Abnormal emotional learning in a rat model of autism exposed to valproic acid in utero
A Banerjee, CT Engineer, BL Sauls, AA Morales, MP Kilgard, JE Ploski
Frontiers in Behavioral Neuroscience, 8, 387
74
cited by
2014
Overexpression of Homer1a in the basal and lateral amygdala impairs fear conditioning and induces an autism-like social impairment
Banerjee A, Luong J, Ho A Saib
Molecular Autism
51
cited by
2016
See all publications on Google Scholar ↗